These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35977978)

  • 1. Verteporfin ameliorates fibrotic aspects of Dupuytren's disease nodular fibroblasts irrespective the activation state of the cells.
    Puerta Cavanzo N; Riesmeijer SA; Holt-Kedde IL; Werker PMN; Piersma B; Olinga P; Bank RA
    Sci Rep; 2022 Aug; 12(1):13940. PubMed ID: 35977978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
    Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
    Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
    BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.
    Zhou C; Zeldin Y; Baratz ME; Kathju S; Satish L
    BMC Musculoskelet Disord; 2019 Mar; 20(1):135. PubMed ID: 30927912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
    Wong M; Mudera V
    J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts.
    Piersma B; de Rond S; Werker PM; Boo S; Hinz B; van Beuge MM; Bank RA
    Am J Pathol; 2015 Dec; 185(12):3326-37. PubMed ID: 26458763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupuytren's Disease Is Mediated by Insufficient TGF-β1 Release and Degradation.
    Oezel L; Wohltmann M; Gondorf N; Wille J; Güven I; Windolf J; Thelen S; Jaekel C; Grotheer V
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional regulation of alpha-smooth muscle actin determines the contractile phenotype of Dupuytren's nodular cells.
    Verjee LS; Midwood K; Davidson D; Eastwood M; Nanchahal J
    J Cell Physiol; 2010 Sep; 224(3):681-90. PubMed ID: 20432463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyl-L-cysteine abrogates fibrogenic properties of fibroblasts isolated from Dupuytren's disease by blunting TGF-beta signalling.
    Kopp J; Seyhan H; Müller B; Lanczak J; Pausch E; Gressner AM; Dooley S; Horch RE
    J Cell Mol Med; 2006; 10(1):157-65. PubMed ID: 16563228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts.
    Szóstek-Mioduchowska AZ; Lukasik K; Skarzynski DJ; Okuda K
    Theriogenology; 2019 Jan; 124():9-17. PubMed ID: 30321755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical and migratory properties of normal, scar, and Dupuytren's fibroblasts.
    Viji Babu PK; Rianna C; Belge G; Mirastschijski U; Radmacher M
    J Mol Recognit; 2018 Sep; 31(9):e2719. PubMed ID: 29701269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between P311 and transforming growth factor beta 1 and its effect on the function of murine fibroblasts].
    Zhang L; Li H; Yao Z; Yang S; He W; Wu J; Luo G
    Zhonghua Shao Shang Za Zhi; 2016 Apr; 32(4):208-15. PubMed ID: 27093932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect and mechnism study of Shengjiyuhong cream on transdifferentiation and collagen production of normal human dermal fibroblasts].
    Sun G; Zhang X; Li H; Pan L; Chen Y; Xu K; FEng D
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Sep; 32(5):365-72. PubMed ID: 30066995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verteporfin as a Medical Treatment in Peyronie's Disease.
    Mohede DCJ; de Jong IJ; Bank RA; van Driel MF
    Sex Med; 2018 Dec; 6(4):302-308. PubMed ID: 30274909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
    Wang W; Liu F; Chen N
    Mediators Inflamm; 2007; 2007():62641. PubMed ID: 18274641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.